HAPPENING NOW
The headlines, minus the noise. Updated in real time. Beta
Experimental pill nearly doubles survival time for people with advanced pancreatic cancer. ‘I actually started crying’
The drug is called daraxonrasib and it blocks a mutated protein that fuels tumor growth in more than 90% of pancreatic cancer cases — a t…
Business & Economy 
AI Summary Powered by Happening Now AI
The drug is called daraxonrasib and it blocks a mutated protein that fuels tumor growth in more than 90% of pancreatic cancer cases — a target that had eluded treatment for decades.
Read full article on FortuneAI summaries can be wrong sometimes—always verify important details using the source article.
SUPPORT HAPPENINGNOW · Independent AI News Intelligence
Enjoyed this article? Consider supporting HappeningNow to help keep independent AI-powered news analysis moving forward. Your contribution helps cover infrastructure, AI summaries, and continued platform development.
Support HappeningNow